About Numab
Numab Therapeutics is an oncology-focused biopharmaceutical company based in the Zurich-area, Switzerland. At Numab, they are writing the next chapter in cancer immunotherapy by creating multi-specific antibodies that enable the pursuit of novel therapeutic strategies.
Founded in 2011 by David Urech, Oliver Middendorp and Peter Lichtlen.
- Founded
- 2011
- Employees
- 11 to 50
- Total funding
- $122M
- Headquarters
- Wädenswil
Leadership
The top of Numab's org chart, with how many people report into each leader.
David Urech
CEO
21 reports
Daniel Snell
SVP, Research & Preclinical Development
4 reports
Martin Stern
Chief Medical Officer
3 reports
Sebastian Meyer
Executive Advisor
3 reports
Roland Helfenstein
Chief Financial Officer
2 reports
Mireia G.
Chief Business Officer
2 reports
James Singleton
Chief Legal Officer, General Counsel and Board Secretary
1 report
Board
Michael K. Bauer
Board Member
David Hong
Advisor
Jing Lou
Board Member
Mario Sznol
Advisor
Matthew Galsky
Advisor
Robert L. Ferris
Advisor
Jobs at Numab
No open positions right now. Explore more companies on TheJobsMap.